Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02625038
Other study ID # 2014-MD-0016
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2014
Est. completion date January 2019

Study information

Verified date March 2019
Source Balgrist University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Target of the study is to evaluate the reduction accuracy of 3D computer-planned osteotomies that are performed with patient-specific instruments.

Due to the higher accuracy achieved it is expected that complaints can be resolved or effectively revealed. The Research hypothesis to prove is "The medical product permits the surgical reduction of deformed bones of the hand and forearm (radius, ulna, distal humerus, carpal, metacarpal, and finger bones) by corrective osteotomy within an accuracy of 2 mm and 2º. Secondary outcome is an assessment of the surgical outcome using the "Disabilities of the Arm, Shoulder and Hand" (DASH) and the "Patient related wrist Evaluation" (PRWE) scores.


Recruitment information / eligibility

Status Completed
Enrollment 110
Est. completion date January 2019
Est. primary completion date January 2019
Accepts healthy volunteers No
Gender All
Age group 15 Years to 99 Years
Eligibility Inclusion criteria

- Posttraumatic or congenital bone deformity or pseudoarthrosis in the field of hand Surgery requiring correction by corrective osteotomy

- Clinical indication for a computer tomography scan of the forearms

- > 18 years old

- written informed consent

Exclusion criteria

- pregnant or nursing women

- other clinical significant accompanying symptoms (Tumor, infection)

- non-compliance of the patient to follow the clinical study protocol, drug or alcohol abuse

- Participation in a different clinical trial within the last 30 days before inclusion or during the study

Study Design


Related Conditions & MeSH terms

  • Posttraumatic or Congenital Bone Deformity

Intervention

Device:
EUDAMED CIV-14-03-011940


Locations

Country Name City State
Switzerland University Hospital Balgrist Zurich

Sponsors (1)

Lead Sponsor Collaborator
Balgrist University Hospital

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary 3D difference between preoperative plan and surgery For each reduced fragment the 3D difference in all 6 degrees of freedom (3xrotation, 3xtranslation) is quantified by comparing pre- and postoperative CT. 42 month
Secondary Surgical Outcome The surgical outcome is assessed by comparing DASH- and PRWE-scores pre- and postoperatively. 42 month